Download PDF
Dtsch Med Wochenschr 2008; 133(25/26): 1370-1374
DOI: 10.1055/s-2008-1081083
Klinischer Fortschritt | Commentary

© Georg Thieme Verlag KG Stuttgart · New York

Infektiologie und Tropenmedizin 2008

Infectiology and tropical medicine 2008M. Löbermann1 , T. Löscher2 , E. C. Reisinger1
  • 1Abteilung für Tropenmedizin und Infektionskrankheiten, Universität Rostock
  • 2 Medizinische Klinik Innenstadt, Abteilung für Infektions- und Tropenmedizin, Ludwig-Maximilians-Universität München
Further Information

Publication History

Publication Date:
13 June 2008 (online)

Also available at
    Permissions and Reprints

Was ist neu?

  • Wert des MRSA-Screenings MRSA-Virulenzfaktoren

  • HIV-Medikamente mit neuem Wirkmechanismus

  • neue Medikamente zur Behandlung invasiver Candida-Infektionen

  • zunehmende Individualisierung der HIV-Therapie

  • 2007: Zunahme von Hantavirus-Infektionen und HIV in Deutschland

  • Ausbruch von Chikungunya-Virus-Erkrankungen in Italien

  • Neue Impfstoffe in Erprobung

Literatur

  • 1 Aponte J J, Aide P, Renom M. et al . Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.  Lancet. 2007;  370 1543-1551
    Google Scholar
  • 2 Bae H G, Domingo C, Tenorio A. et al . Immune Response during Adverse Events after 17D-Derived Yellow Fever Vaccination in Europe.  J Infect Dis. 2008 Apr 15 [Epub ahead of print]; 
    Google Scholar
  • 3 Becker K L, Snider R, Nylen E S. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations.  Crit Care Med. 2008;  36 941-52
    Google Scholar
  • 4 Cox-Singh J, Davis T M, Lee K S. et al . Plasmodium knowlesi malaria in humans is widely distributed and potentially life threatening.  Clin Infect Dis. 2008;  46 172-173
    Google Scholar
  • 5 Diekema D J, Climo M. Preventing MRSA infections: finding it is not enough.  JAMA. 2008;  299 1190-2
    Google Scholar
  • 6 Diep B A, Chambers H F, Graber C J. et al . Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men.  Ann Intern Med. 2008;  148 249-57
    Google Scholar
  • 7 Eiland E H, Hassoun A, English T. Points of concern related to the micafungin versus caspofungin trial.  Clin Infect Dis. 2008;  46 640-1
    Google Scholar
  • 8 Esté J A, Telenti A. HIV entry inhibitors.  Lancet. 2007;  370 81-8
    Google Scholar
  • 9 Harbarth S, Fankhauser C, Schrenzel J. et al . Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients.  JAMA. 2008;  299 1149-57
    Google Scholar
  • 10 Kamar N, Selves J, Mansuy J M. et al . Hepatitis E virus and chronic hepatitis in organ-transplant recipients.  N Engl J Med. 2008;  358 811-817
    Google Scholar
  • 11 Kelly C, Arnold R, Galloway Y, O’Hallahan J. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.  Am J Epidemiol. 2007;  166 817-823
    Google Scholar
  • 12 Kindberg E, Mickiene A, Ax C. et al . A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis.  J Infect Dis. 2008;  197 266-9
    Google Scholar
  • 13 Lim J K, Louie C Y, Glaser C. et al . Genetic deficiency of chemokine receptor CCR5 is a strong risk factor for symptomatic West Nile virus infection: a meta-analysis of 4 cohorts in the US epidemic.  J Infect Dis. 2008;  197 262-5
    Google Scholar
  • 14 Leroux-Roels I, Bernhard R, Gérard P. et al . Broad Clade 2 cross-reactive immunity induced by an adjuvanted clade 1 rH5N1 pandemic influenza vaccine.  PLoS ONE. 2008;  3 e1665
    Google Scholar
  • 15 Leroux-Roels I, Borkowski A, Vanwolleghem T. et al . Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.  Lancet. 2007;  370 580-589
    Google Scholar
  • 16 Lyons A, Kanesathasan N, Kuschner R A. et al . A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.  Vaccine. 2007;  25 3445-3453
    Google Scholar
  • 17 Mallal S, Phillips E, Carosi G. et al . PREDICT-1 Study Team. HLA-B*5701 screening for hypersensitivity to abacavir.  N Engl J Med. 2008;  358 568-79
    Google Scholar
  • 18 Newton P N, Fernández F M, Plançon A. et al . A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia.  PLoS Med. 2008;  5 e32
    Google Scholar
  • 19 Nicolau D P. Carbapenems: a potent class of antibiotics.  Expert Opin Pharmacother. 2008;  9 23-37
    Google Scholar
  • 20 Nobre V, Harbarth S, Graf J D. et al . Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial.  Am J Respir Crit Care Med. 2008;  177 498-505
    Google Scholar
  • 21 Pappas P G, Rotstein C M, Betts R F. et al . Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.  Clin Infect Dis. 2007;  45 883-93
    Google Scholar
  • 22 Péron J M, Bureau C, Poirson H. et al . Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy.  J Viral Hepat. 2007;  14 298-303
    Google Scholar
  • 23 Rezza G, Nicoletti L, Angelini R. et al, CHIKV study group . Infection with chikungunya virus in Italy: an outbreak in a temperate region.  Lancet. 2007;  370 1840-6
    Google Scholar
  • 24 Riddler S A, Haubrich R, DiRienzo A G. et al, AIDS Clinical Trials Group Study A5142 Team . Class-sparing regimens for initial treatment of HIV-1 infection.  N Engl J Med. 2008;  358 2095-106
    Google Scholar
  • 25 Rittenhouse S, Biswas S, Broskey J. et al . Selection of retapamulin, a novel pleuromutilin for topical use.  Antimicrob Agents Chemother. 2006;  50 3882-5
    Google Scholar
  • 26 Robert-Koch-Institut . HIV-Infektionen und AIDS-Erkrankungen in Deutschland.  Epidemiol Bull. 2008;  Sonderausgabe A
    Google Scholar
  • 27 Robert-Koch-Institut . Zum Auftreten von caMRSA „USA300” bei MSM in Deutschland.  Epidemiol Bull. 2008;  11 88-89
    Google Scholar
  • 28 Robert-Koch-Institut . Massive Zunahme der Hantavirus-Infektionen in den ersten Monaten des Jahres 2007.  Epidemiol Bull. 2008;  24 202-204
    Google Scholar
  • 29 Robicsek A, Beaumont J L, Paule S M. et al . Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals.  Ann Intern Med. 2008;  148 409-18
    Google Scholar
  • 30 Rodríguez-Nóvoa S, García-Gascó P, Blanco F. et al . Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards.  AIDS Res Hum Retroviruses. 2007;  23 1374-6
    Google Scholar
  • 31 Sandek A, Springer J, Habedank D. et al . Procalcitonin-guided antibiotic treatment in heart failure.  Lancet. 2004;  363 1555
    Google Scholar
  • 32 Scherer J, Boucher C A, Baxter J D. et al .Improving the prediction of virological response to tipranavir: the development of a tipranavir weighted score. [Poster P3.4/07]. Madrid, Spain; 11th European AIDS Conference (2007)
    Google Scholar
  • 33 Seyler T, Rizzo C, Finarelli A C. et al . Autochthonous chikungunya virus transmission may have occurred in Bologna, Italy, during the summer 2007 outbreak.  Euro Surveill. 2008;  13 8015
    Google Scholar
  • 34 Shrestha M P, Scott R M, Joshi D M. et al . Safety and efficacy of a recombinant hepatitis E vaccine.  Engl J Med. 2007;  356 895-903
    Google Scholar
  • 35 Simasathien S, Thomas S J, Watanaveeradej V. et al . Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.  Am J Trop Med Hyg. 2008;  78 426-33
    Google Scholar
  • 36 Skiest D J, Brown K, Cooper T W. et al . Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients.  J Infect. 2007;  54 427-34
    Google Scholar
  • 37 Stellbrink H J. Antiviral drugs in the treatment of AIDS: what is in the pipeline?.  Eur J Med Res. 2007;  12 483-95
    Google Scholar
  • 38 Swenson D L, Warfield K L, Larsen T. et al . Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.  Expert Rev Vaccines. 2008;  7 417-29
    Google Scholar
  • 39 Towner J S, Pourrut X, Albariño C G. et al . Marburg virus infection detected in a common African bat.  PLoS ONE. 2007;  2 e764
    Google Scholar
  • 40 Van Lunzen J. Treatment of heavily antiretroviral-experienced HIV-infected patients.  AIDS Rev. 2007;  9 246-53
    Google Scholar
  • 41 Van Lunzen J. How will CCR5 antagonists influence the recommendations for the antiretroviral treatment of HIV-1 infection.  Eur J Med Res. 2007;  12 435-40
    Google Scholar
  • 42 Wang R, Braughton K R, Kretschmer D. et al . Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA.  Nat Med. 2007;  13 1510-4
    Google Scholar
  • 43 Wilkin T J, Su Z, Kuritzkes D R. et al . HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.  Clin Infect Dis. 2007;  44 591-5
    Google Scholar
  • 44 Woltering R, Hoffmann G, Daniels-Haardt I. et al . MRSA-Prävalenz in medizinischen und pflegerischen Einrichtungen eines Landkreises.  Dtsch Med Wochenschr. 2008;  133 999-1003
    Google Scholar
  • 45 Wymann M N, Flacio E, Radczuweit S, Patocchi N, Luthy P. Asian tiger mosquito (Aedes albopictus) - a threat for Switzerland?.  Euro Surveill. 2008;  13 8058
    Google Scholar
  • 46 Yang L P, Keam S J. Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.  Drugs. 2008;  68 855-73
    Google Scholar
  • 47 Zhanel G G, Wiebe R, Dilay L. et al . Comparative review of the carbapenems.  Drugs. 2007;  67 1027-52
    Google Scholar

Prof. Dr. Emil C. Reisinger

Universität Rostock, Abteilung für Tropenmedizin und Infektionskrankheiten

Ernst Heydemann Straße 6

18057 Rostock

Phone: 0381/4947510

Fax: 0381/4947509

Email: emil.reisinger@medizin.uni-rostock.de

      >